Pediatric Endocrinology

On this page
Comprehensive care for pediatric hormone disorders
At UCSF Benioff Children's Hospitals, we offer family-centered care for children with hormone-related conditions, from common disorders to rare and complex diseases.
Our specialists understand the unique needs of growing bodies and are committed to helping your child thrive.
Our pediatric endocrinology services
Our team includes board-certified, fellowship-trained pediatric endocrinologists. We treat a wide range of conditions, including:
Adrenal, pituitary and thyroid disorders
Diabetes
Growth concerns, such as failure to thrive and unusually short or tall stature
Hypoglycemia (low blood sugar)
Lipid disorders, such as high cholesterol or triglyceride levels
Metabolic bone diseases
Obesity and other weight concerns
Puberty disorders
Advanced diabetes care, designed for kids
We offer compassionate, family-centered care for children, adolescents and young adults with type 1 and type 2 diabetes. Our nationally recognized program brings together leading specialists and a dedicated support team that puts your child's needs first. We provide personalized treatment and education to support long-term health.
Learn more about pediatric diabetes care.
Specialized expertise in pediatric lipid disorders
At UCSF, we provide ongoing care for children with lipid disorders to reduce their risk of heart attack, stroke and other health complications. As a leader in lipid disorder research, our program offers access to the latest therapies through clinical trials.
Learn more about pediatric lipid disorder treatment.
Comprehensive care for pediatric hormone disorders
At UCSF Benioff Children's Hospitals, we offer family-centered care for children with hormone-related conditions, from common disorders to rare and complex diseases.
Our specialists understand the unique needs of growing bodies and are committed to helping your child thrive.
Our pediatric endocrinology services
Our team includes board-certified, fellowship-trained pediatric endocrinologists. We treat a wide range of conditions, including:
Adrenal, pituitary and thyroid disorders
Diabetes
Growth concerns, such as failure to thrive and unusually short or tall stature
Hypoglycemia (low blood sugar)
Lipid disorders, such as high cholesterol or triglyceride levels
Metabolic bone diseases
Obesity and other weight concerns
Puberty disorders
Advanced diabetes care, designed for kids
We offer compassionate, family-centered care for children, adolescents and young adults with type 1 and type 2 diabetes. Our nationally recognized program brings together leading specialists and a dedicated support team that puts your child's needs first. We provide personalized treatment and education to support long-term health.
Learn more about pediatric diabetes care.
Specialized expertise in pediatric lipid disorders
At UCSF, we provide ongoing care for children with lipid disorders to reduce their risk of heart attack, stroke and other health complications. As a leader in lipid disorder research, our program offers access to the latest therapies through clinical trials.
Learn more about pediatric lipid disorder treatment.
Locations (dynamic)
Providers (dynamic)

Alison Reed, MD
Pediatrics • Pediatric Endocrinology
Martin Thelin, MD
Pediatric Endocrinology
Anthony Parish, MD
Pediatric Endocrinology
June M. Tester, MD, MPH
Pediatrics • Pediatric Endocrinology
Providers (manual)

Tariq Ahmad, MD
Endocrinology • Pediatric Endocrinology
Sonali Belapurkar, MD
Pediatric Endocrinology
Gina Capodanno, MD, MS
Pediatric Endocrinology • Endocrinology
Eda Cengiz, MD
Pediatric Endocrinology
Awards & achievements
Related conditions & treatments
Conditions
- Adrenal Disorders
- Delayed Puberty
- Diabetes Mellitus
- Disorders of Sexual Development
- Endocrine Disorders
- Growth Disorders
- Hashimoto Thyroiditis
- Hypercholesterolemia
- Hyperthyroidism
Treatments
- Diabetes Education
Clinical trials
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 DiabetesOpens in a new window
This multi-center randomized controlled trial will assess the safety and efficacy of ATG followed by either adalimumab or verapamil in preserving insulin secretion 2 years from randomization in persons aged 9 to <21 with recent-onset stage 3 T1D.INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 DiabetesOpens in a new window
INHALE-1st is a Phase 2, single-arm, multi-center, clinical study evaluating the safety and efficacy of Afrezza in combination with subcutaneously-injected basal insulin (BI) for youth 6 to <18 years old with newly diagnosed stage 3 type 1 diabetes (T1D). The study will also evaluate the effect of an Afrezza plus BI reigmen on participant and parent/legally authorized representative satisfaction...Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial HypercholesterolemiaOpens in a new window
This is a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in children (aged 2 to <12 years) with homozygous familial hypercholesterolemia (HoFH) and elevated low density lipoprotein cholesterol (LDLC).A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)Opens in a new window
The main purpose of this study is to evaluate additional dosing options for dulaglutide in pediatric participants with Type 2 Diabetes. Participation in this study will last about 8 months.A Phase 2 Study of Vosoritide in Children With Idiopathic Short StatureOpens in a new window
The purpose of this study is to evaluate i) the effect of multiple doses of vosoritide and ii) the effect of the therapeutic dose of vosoritide compared to human growth hormone (hGH)(hGH; only in the United States), in children with idiopathic short stature (ISS).



















